Publications
5539 Results
- Journal / Conference
- Proc of the American Society of Clinical Oncology 22:396(#1591)
- Year
- 2003
- Research Committee(s)
- Genitourinary
- Study Number(s)
- SWOG-9346
Determinants of prostate specific antigen (PSA) normalization in prostate cancer (PCa) patients (pts) treated with androgen deprivation (AD) on Southwest Oncology Group (SWOG) study 9346 (INT-0162).
- Journal / Conference
- Proc of the American Society of Clinical Oncology 22:529(#2127)
- Year
- 2003
African Americans have worse survival in hormone-related cancers. a Southwest Oncology Group (SWOG) study.
- Journal / Conference
- Proc of the American Society of Clinical Oncology 22:621(#2497)
- Year
- 2003
- Research Committee(s)
- Lung
- Study Number(s)
- SWOG-9336
Phase III comparison of concurrent chemotherapy plus radiotherapy (CT/RT) and CT/RT followed by surgical resection for stage IIIA (pN2) non-small cell lung cancer (NSCLC): initial results from intergroup trial 0139 (RTOG 93-09).
- Journal / Conference
- Proc of the American Society of Clinical Oncology 22:387(#1553)
- Year
- 2003
- Research Committee(s)
- Genitourinary
- Study Number(s)
- S0109
A phase II study of flavopiridol (Flavo) in patients (pts) with advanced renal cell cancer: results of Southwest Oncology Group trial S0109.
- Journal / Conference
- Proc of the American Society of Clinical Oncology 22:622(#2502)
- Year
- 2003
- Research Committee(s)
- Lung
- Study Number(s)
- S0003
S0003: Paclitaxel/carboplatin (PC) v PC + tirapazamine (PCT) in advanced non-small cell lung cancer (NSCLC). A phase III Southwest Oncology Group (SWOG) trial.
- Journal / Conference
- Proc of the American Society of Clinical Oncology 22:251(#1006)
- Year
- 2003
- Research Committee(s)
- Gastrointestinal
- Study Number(s)
- SWOG-9304 (INT-0144)
Intergroup 0144 - phase III trial of 5-FU based chemotherapy regimens plus radiotherapy (XRT) in postoperative adjuvant rectal cancer. Bolus 5-FU vs prolonged venous infusion (PVI) before and after XRT + PVI vs bolus 5-FU + leucovorin (LV) + levamisole (LEV) before and after XRT + bolus 5-FU + LV.
- Journal / Conference
- Proc of the American Society of Clinical Oncology 22:814(#3271)
- Year
- 2003
- Research Committee(s)
- Sarcoma
- Study Number(s)
- S0033
Phase III dose-randomized study of imatinib mesylate (STI571) for GIST: Intergroup S0033 early results.
- Journal / Conference
- Proc of the American Society of Clinical Oncology 22:383(#1540)
- Year
- 2003
- Research Committee(s)
- Genitourinary
- Study Number(s)
- SWOG-8710 (INT-0080) (EST-1887) (CALGB-8891)
Surgical variables impact bladder cancer outcomes: a cooperative group report.
- Journal / Conference
- Proc of the American Society of Clinical Oncology 22:633(#2545)
- Year
- 2003
- Research Committee(s)
- Lung
- Study Number(s)
- SWOG-9252 (INT-0115) (EST-3590) (RTOG 91-05) (NCCTG-91-24-51) (CALGB-9393)
Post-operative radiotherapy (PORT) or chemoradiotherapy (CPORT) following resection of stages II and IIIa non-small cell lung cancer (NSCLC) leads to higher than expected risk of death from intercurrent disease (DID).
- Journal / Conference
- Proc of the American Society of Clinical Oncology 22:272(#1092)
- Year
- 2003
- Research Committee(s)
- Gastrointestinal
- Study Number(s)
- S9923